6.75
price down icon1.89%   -0.13
after-market Dopo l'orario di chiusura: 6.74 -0.010 -0.15%
loading
Precedente Chiudi:
$6.88
Aprire:
$6.89
Volume 24 ore:
932.17K
Relative Volume:
0.33
Capitalizzazione di mercato:
$731.66M
Reddito:
$42.51M
Utile/perdita netta:
$-116.49M
Rapporto P/E:
-6.0268
EPS:
-1.12
Flusso di cassa netto:
$-120.82M
1 W Prestazione:
-1.60%
1M Prestazione:
+25.93%
6M Prestazione:
+122.04%
1 anno Prestazione:
-31.89%
Intervallo 1D:
Value
$6.71
$7.00
Intervallo di 1 settimana:
Value
$6.36
$7.14
Portata 52W:
Value
$1.03
$12.02

Tango Therapeutics Inc Stock (TNGX) Company Profile

Name
Nome
Tango Therapeutics Inc
Name
Telefono
(857) 320-4900
Name
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Name
Dipendente
155
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
TNGX's Discussions on Twitter

Confronta TNGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TNGX
Tango Therapeutics Inc
6.75 745.75M 42.51M -116.49M -120.82M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-17 Iniziato Jefferies Buy
2024-04-04 Iniziato Cantor Fitzgerald Overweight
2024-02-12 Iniziato Piper Sandler Overweight
2023-12-08 Iniziato B. Riley Securities Buy
2022-10-20 Aggiornamento H.C. Wainwright Neutral → Buy
2021-09-20 Iniziato SVB Leerink Outperform
Mostra tutto

Tango Therapeutics Inc Borsa (TNGX) Ultime notizie

pulisher
Jul 24, 2025

Will Tango Therapeutics Inc. stock benefit from AI tech trendsSuperior capital gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Tango Therapeutics Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Tango Therapeutics Inc. stockTremendous growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Tango Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Optimistic Investors Push Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Up 31% But Growth Is Lacking - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Tango Therapeutics Inc. stock priceFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 19, 2025

Will Tango Therapeutics Inc. stock benefit from interest rate changesMarket Timing Advice - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

How high can Tango Therapeutics Inc. stock price go in 2025Daily Volume Leaders - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Can Tango Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Tango Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth Strategies - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Tango Therapeutics (TNGX) Soars 5.96% on Strong Q2 Earnings - AInvest

Jul 09, 2025
pulisher
Jul 06, 2025

Tango Therapeutics’ SWOT analysis: biotech stock’s potential in precision cancer therapies - Investing.com

Jul 06, 2025
pulisher
Jul 06, 2025

Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - MSN

Jul 06, 2025
pulisher
Jul 03, 2025

HC Wainwright Issues Optimistic Forecast for TNGX Earnings - Defense World

Jul 03, 2025
pulisher
Jun 30, 2025

Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 3000 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

H.C. Wainwright reiterates Buy rating on Tango Therapeutics stock - Investing.com

Jun 30, 2025
pulisher
Jun 27, 2025

Tango Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire

Jun 27, 2025
pulisher
Jun 27, 2025

Tango Therapeutics Launches Groundbreaking Trial for Advanced Pancreatic and Lung Cancer Treatment - Stock Titan

Jun 27, 2025
pulisher
Jun 25, 2025

Exchange Traded Concepts LLC Purchases 47,901 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Jun 25, 2025
pulisher
Jun 22, 2025

Tango Therapeutics (TNGX.O) Surges 7.5% Amid Quiet Fundamental Landscape - AInvest

Jun 22, 2025
pulisher
Jun 21, 2025

Tango Therapeutics' Mysterious 7.5% Spike: What’s Behind the Move? - AInvest

Jun 21, 2025
pulisher
Jun 16, 2025

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jun 16, 2025
pulisher
Jun 14, 2025

Tango Therapeutics’ SWOT analysis: stock poised for growth amid clinical trials - Investing.com

Jun 14, 2025

Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):